AIMS: The left atrial appendage (LAA) produces natriuretic peptides and its removal or occlusion might increase the risk of heart failure (HF). We aimed to investigate the incidence of HF after LAA occlusion or removal (LAAO) in the Left Atrial Appendage Occlusion Study (LAAOS III). METHODS AND RESULTS: Patients (n = 4811) with atrial fibrillation (AF) and a CHA2DS2-VASc score ≥2, who were having cardiac surgery for another indication, were randomized to undergo surgical LAAO or not. We compared the composite outcome of HF-related hospitalizations and HF death between the two groups. HF assessment required clinical and radiographic evidence of HF. Analyses included a landmark analysis before and after 30 days and subgroups. Mean age was 71.2 years, 67.5% were male and 57.0% had prior HF. Over a mean follow-up of 3.8 years, 396 (8.3%) patients met the composite HF outcome: 209 (8.8%) with LAAO (n = 2379) and 187 (7.8%) without LAAO (n = 2391) (hazard ratio [HR] 1.12, 95% confidence interval [CI] 0.92-1.37, p = 0.25). There was no difference between the two groups in the first 30 days (1.6% vs. 1.1%; p = 0.12) and thereafter (7.6% vs. 7.1%; p = 0.57). Subgroups based on age, sex, body mass index, AF type, prior HF, cardiac rhythm or left ventricular ejection fraction showed consistent results. There was no difference in HF outcomes with LAAO between the cut-and-sew (HR 0.93, 95% CI 0.70-1.23, p = 0.62) versus other closure methods (HR 1.05, 95% CI 0.77-1.41, p = 0.77). CONCLUSIONS: Left atrial appendage occlusion or removal at the time of cardiac surgery does not appear to alter the risk of HF-related hospitalization or death. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov NCT01561651.

Auckland City Hospital Auckland New Zealand

Department Medicine and Surgical Science University of Foggia and Santa Maria Hospital GVM Care and Research Bari Italy

Department of Cardiac Surgery University Hospitals Leuven Leuven Belgium

Department of Cardiology and Cardiovascular Research Institute Basel University Hospital Basel University of Basel Basel Switzerland

Department of Cardiology Copenhagen University Hospital Rigshospitalet Copenhagen Denmark

Department of Clinical Sciences Malmö Lund University Lund Sweden

Department of Surgical Medical and Molecular Pathology and Critical Care University of Pisa Pisa Italy

Division of Cardiology Department of Medicine K2 Karolinska University Hospital Solna Karolinska Institutet Stockholm Sweden

Hamilton Health Sciences Hamilton ON Canada

Institute for Clinical and Experimental Medicine Prague Czech Republic

McMaster University Hamilton ON Canada

National Heart and Lung Institute Imperial College London London UK

Population Health Research Institute Hamilton ON Canada

Rhön Klinikum Campus Bad Neustadt Bad Neustadt Germany

University of Melbourne and Royal Melbourne Hospital Melbourne VIC Australia

Zobrazit více v PubMed

Whitlock R, Healey J, Vincent J, Brady K, Teoh K, Royse A, et al. Rationale and design of the Left Atrial Appendage Occlusion Study (LAAOS) III. Ann Cardiothorac Surg 2014;3:45–54. 10.3978/j.issn.2225-319X.2013.12.06 PubMed DOI PMC

Whitlock RP, Belley‐Cote EP, Paparella D, Healey JS, Brady K, Sharma M, et al. LAAOS III Investigators. Left atrial appendage occlusion during cardiac surgery to prevent stroke. N Engl J Med 2021;384:2081–2091. 10.1056/NEJMoa2101897 PubMed DOI

Healey JS, Oldgren J, Ezekowitz M, Zhu J, Pais P, Wang J, et al.; RE‐LY Atrial Fibrillation Registry and Cohort Study Investigators . Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: A cohort study. Lancet 2016;388:1161–1169. 10.1016/S0140-6736(16)30968-0 PubMed DOI

Patel NJ, Deshmukh A, Pant S, Singh V, Patel N, Arora S, et al. Contemporary trends of hospitalization for atrial fibrillation in the United States, 2000 through 2010: Implications for healthcare planning. Circulation 2014;129:2371–2379. 10.1161/CIRCULATIONAHA.114.008201 PubMed DOI

Tabata T, Oki T, Yamada H, Iuchi A, Ito S, Hori T, et al. Role of left atrial appendage in left atrial reservoir function as evaluated by left atrial appendage clamping during cardiac surgery. Am J Cardiol 1998;81:327–332. 10.1016/s0002-9149(97)00903-x PubMed DOI

Vargas‐Barron J, Saucedo‐Orozco H, Sanchez‐Mendoza A, Marquez‐Velasco R, Catrip‐Torres JM, Jimenez‐Rojas V, et al. Modification of serum natriuretic peptide profile and echocardiographic parameters after surgical left atrial appendage exclusion/resection during mitral valve surgery. Heart Lung Circ 2021;30:751–757. 10.1016/j.hlc.2020.09.922 PubMed DOI

Hoit BD, Shao Y, Gabel M. Influence of acutely altered loading conditions on left atrial appendage flow velocities. J Am Coll Cardiol 1994;24:1117–1123. 10.1016/0735-1097(94)90878-8 PubMed DOI

Krisai P, Johnson LSB, Moschovitis G, Benz A, Ramasundarahettige C, McIntyre WF, et al. Incidence and predictors of heart failure in patients with atrial fibrillation. CJC Open 2021;3:1482–1489. 10.1016/j.cjco.2021.07.016 PubMed DOI PMC

Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA, et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: The Framingham Heart Study. Circulation 2003;107:2920–2925. 10.1161/01.CIR.0000072767.89944.6E PubMed DOI

Wong JA, Conen D, Van Gelder IC, McIntyre WF, Crijns HJ, Wang J, et al. Progression of device‐detected subclinical atrial fibrillation and the risk of heart failure. J Am Coll Cardiol 2018;71:2603–2611. 10.1016/j.jacc.2018.03.519 PubMed DOI

Johnson LSB, Oldgren J, Barrett TW, McNaughton CD, Wong JA, McIntyre WF, et al. LVS‐HARMED risk score for incident heart failure in patients with atrial fibrillation who present to the emergency department: Data from a world‐wide registry. J Am Heart Assoc 2021;10:e017735. 10.1161/JAHA.120.017735 PubMed DOI PMC

Lip GYH, Nieuwlaat R, Pisters R, Lane DA, Crijns HJGM. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor‐based approach: The Euro Heart Survey on Atrial Fibrillation. Chest 2010;137:263–272. 10.1378/chest.09-1584 PubMed DOI

Morita S, Malik AH, Kuno T, Ando T, Kaul R, Yandrapalli S, et al. Analysis of outcome of 6‐month readmissions after percutaneous left atrial appendage occlusion. Heart 2022;108:606–612. 10.1136/heartjnl-2021-319345 PubMed DOI

Piccini JP. Atrial fibrillation and heart failure: Too much talk and not enough action. JACC Clin Electrophysiol 2023;9:581–582. 10.1016/j.jacep.2023.03.003 PubMed DOI PMC

Moreyra AE, Deng Y, Wilson AC, Cosgrove NM, Kostis WJ, Kostis JB; MIDAS 18 Study Group . Incidence and trends of heart failure admissions after coronary artery bypass grafting surgery. Eur J Heart Fail 2013;15:46–53. 10.1093/eurjhf/hfs154 PubMed DOI

Vassileva CM, Ghazanfari N, Spertus J, McNeely C, Markwell S, Hazelrigg S. Heart failure readmission after mitral valve repair and replacement: Five‐year follow‐up in the Medicare population. Ann Thorac Surg 2014;98:1544–1550. 10.1016/j.athoracsur.2014.07.040 PubMed DOI

Lakkireddy D, Turagam M, Afzal MR, Rajasingh J, Atkins D, Dawn B, et al. Left atrial appendage closure and systemic homeostasis: The LAA HOMEOSTASIS study. J Am Coll Cardiol 2018;71:135–144. 10.1016/j.jacc.2017.10.092 PubMed DOI

Hoit BD, Shao Y, Tsai LM, Patel R, Gabel M, Walsh RA. Altered left atrial compliance after atrial appendectomy. Influence on left atrial and ventricular filling. Circ Res 1993;72:167–175. 10.1161/01.res.72.1.167 PubMed DOI

Cox JL, Schuessler RB, D'Agostino HJ, Stone CM, Chang BC, Cain ME, et al. The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure. J Thorac Cardiovasc Surg 1991;101:569–583. PubMed

Healey JS, Crystal E, Lamy A, Teoh K, Semelhago L, Hohnloser SH, et al. Left Atrial Appendage Occlusion Study (LAAOS): Results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke. Am Heart J 2005;150:288–293. 10.1016/j.ahj.2004.09.054 PubMed DOI

Santhanakrishnan R, Wang N, Larson MG, Magnani JW, McManus DD, Lubitz SA, et al. Atrial fibrillation begets heart failure and vice versa: Temporal associations and differences in preserved versus reduced ejection fraction. Circulation 2016;133:484–492. 10.1161/CIRCULATIONAHA.115.018614 PubMed DOI PMC

Rillig A, Magnussen C, Ozga AK, Suling A, Brandes A, Breithardt G, et al. Early rhythm control therapy in patients with atrial fibrillation and heart failure. Circulation 2021;144:845–858. 10.1161/CIRCULATIONAHA.121.056323 PubMed DOI PMC

Zobrazit více v PubMed

ClinicalTrials.gov
NCT01561651